Comparison of NoaScope to the Conventional Stethoscope for Auscultation of Heart and Lung Sounds

Innova Smart Technologies

Status: Completed

Conditions: Chest Pathology

Treatments: Device: NoaScope

Study type: Interventional

Funder types: Other

Identifiers

NCT05252130

NoaScope-1 RMI

Details and patient eligibility

About

Assessing non-inferiority of a newly developed electronic stethoscope NoaScope in comparison with the conventional 3M Littmann stethoscope

Full description

The enrolled population will include adults with a history of heart and lung complications. The enhanced sound quality of the electronic stethoscope and its non-inferiority to the traditional/conventional 3M Littmann stethoscope will be assessed through auscultation examination of every patient by a health professional (consultant, medical resident, and house officer) with both the electronic stethoscope and 3M Littmann/traditional/conventional stethoscope

Enrollment: 47 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ages: 18 years or older (male and female)
• Hospital admitted or Out Patient Department
• Written consent provided

Exclusion criteria

• Age <18
• ICU admitted
• Written consent not provided

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

47 participants in 1 patient group

Auscultation with a newly developed electronic stethoscope: NoaScope

Experimental group

Description:

Identification of abnormal heart and lung sounds in study participants

Treatment:

Device: NoaScope